Corrigendum: Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry
Alessandra Francica1*, 
Antonio Loforte2,3, 
Matteo Attisani3, 
Massimo Maiani4, Attilio Iacovoni5, Teodora Nisi6, 
Marina Comisso7, Amedeo Terzi5, Michele De Bonis6, Igor Vendramin4, 
Massimo Boffini3, Francesco Musumeci7, Giovanni Battista Luciani1, Mauro Rinaldi3, Davide Pacini2 and Francesco Onorati1- 1Division of Cardiac Surgery, University Hospital of Verona, Verona, Italy
- 2Division of Cardiac Surgery, S. Orsola University Hospital, IRCCS Bologna, Bologna, Italy
- 3City of Health and Science Hospital, Cardiac Surgery University Unit, University of Turin, Turin, Italy
- 4Division of Cardiac Surgery, Ospedale S. Maria della Misericordia, Udine, Italy
- 5Division of Cardiac Surgery, Papa Giovanni XXII Hospital of Bergamo, Bergamo, Italy
- 6Division of Cardiac Surgery, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy
- 7Division of Cardiac Surgery, San Camillo Forlanini Hospital, Rome, Italy
by Francica A, Loforte A, Attisani M, Maiani M, Iacovoni A, Nisi T, Comisso M, Terzi A, De Bonis M, Vendramin I, Boffini M, Musumeci F, Luciani GB, Rinaldi M, Pacini D and Onorati F (2023). Transpl Int. 36:11675. doi: 10.3389/ti.2023.11675
In the original article, there was a mistake in the Graphical Abstract as published. The propensity-score matching survival was incorrectly given as “64.1% vs. 81.3% (p .02)”. The correct values are “64.1% for HM3 vs. 41.7% in HVAD (p 0.02)”. The Kaplan-Meier curve is correct, it was just a transcription error.
GRAPHICAL ABSTRACT
GRAPHICAL ABSTRACT
The corrected Graphical Abstract appears below.
The same mistake was present in the text body. A correction has been made to the Abstract and to the Results section:
Abstract: “The propensity-score matching analysis (130 pairs of HVAD vs. HM3) confirmed a significantly lower 5 years survival (41.7% vs. 64.1%; p 0.02)…”
Results, Propensity Matched Population: “HVAD patients confirmed a significantly lower 5 years survival (64.1% vs. 41.7%; p 0.02) (Figure 2B)…”
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: continuous-flow LVAD, HeartMate3, HeartWare, full-magnetic levitation pump, hybrid levitation system pump
Citation: Francica A, Loforte A, Attisani M, Maiani M, Iacovoni A, Nisi T, Comisso M, Terzi A, De Bonis M, Vendramin I, Boffini M, Musumeci F, Luciani GB, Rinaldi M, Pacini D and Onorati F (2023) Corrigendum: Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry. Transpl Int 36:12088. doi: 10.3389/ti.2023.12088
Received: 21 September 2023; Accepted: 25 September 2023;
Published: 09 October 2023.
Copyright © 2023 Francica, Loforte, Attisani, Maiani, Iacovoni, Nisi, Comisso, Terzi, De Bonis, Vendramin, Boffini, Musumeci, Luciani, Rinaldi, Pacini and Onorati. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Alessandra Francica, alessandrafrancica@yahoo.it
